APO Research
Talk to an analyst

APO RESEARCH · REPORT

Oral Contrast Agent

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Oral Contrast Agent Market Outlook and Growth Opportunities 2026

19 December 2025194 pages

Choose your research edition.

Industry ResearchOral Contrast Agent Industry Research Report 2026128 pages · $2,950 USDIndustry Growth & TrendsGlobal Oral Contrast Agent Industry Growth and Trends Forecast to 2032101 pages · $3,450 USDMarket StructureGlobal Oral Contrast Agent Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032199 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Oral Contrast Agent Market Outlook and Growth Opportunities 2026194 pages · $4,250 USDMarket Analysis & ForecastGlobal Oral Contrast Agent Market Analysis and Forecast 2026-2032195 pages · $4,950 USD

Market perspective

The global Oral Contrast Agent market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Oral Contrast Agent is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Oral Contrast Agent is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Oral Contrast Agent is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Oral Contrast Agent market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Oral Contrast Agent market include Daiichi Sankyo (Japan), Bayer HealthCare (Germany), Unijules Life Sciences (India), Taejoon Pharm (South Korea), Spago Nanomedicine (Sweden), Magnus Health (India), Lantheus (US), Jodas (India) and J.B. Chemicals and Pharmaceuticals (India), among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Oral Contrast Agent market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Oral Contrast Agent and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Oral Contrast Agent sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Oral Contrast Agent market size, projected growth trends, production technologies, key applications, and end-use industries.

Oral Contrast Agent Segment by Company

Daiichi Sankyo (Japan)

Bayer HealthCare (Germany)

Unijules Life Sciences (India)

Taejoon Pharm (South Korea)

Spago Nanomedicine (Sweden)

Magnus Health (India)

Lantheus (US)

Jodas (India)

J.B. Chemicals and Pharmaceuticals (India)

Guerbet (France)

GE Healthcare (US)

Bracco Imaging (Italy)

Oral Contrast Agent Segment by Type

Microbubble Contrast Media

Gadolinium-based Contrast Media

Iodinated Contrast Media

Barium-based Contrast Media

Oral Contrast Agent Segment by Application

Cardiovascular Disorders

Gastrointestinal Disorders

Nephrological Disorders

Neurological Disorders

Musculoskeletal Disorders

Cancer

Oral Contrast Agent Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global Oral Contrast Agent status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions Oral Contrast Agent market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Oral Contrast Agent significant trends, drivers, influence factors in global and regions.

6. To analyze Oral Contrast Agent competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Oral Contrast Agent market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Oral Contrast Agent and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Oral Contrast Agent.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Oral Contrast Agent market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Oral Contrast Agent industry.

Chapter 3: Detailed analysis of Oral Contrast Agent manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of Oral Contrast Agent in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of Oral Contrast Agent in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Oral Contrast Agent Industry Trends Table 2. Oral Contrast Agent Industry Drivers Table 3. Oral Contrast Agent Industry Opportunities and Challenges Table 4. Oral Contrast Agent Industry Restraints Table 5. Global Oral Contrast Agent Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Oral Contrast Agent Revenue Share by Company (2021-2026) Table 7. Global Oral Contrast Agent Sales Volume by Company (K Units) & (2021-2026) Table 8. Global Oral Contrast Agent Sales Volume Share by Company (2021-2026) Table 9. Global Oral Contrast Agent Average Price (US$/Unit) of Company (2021-2026) Table 10. Global Oral Contrast Agent Company Ranking, (2024-2026) & (USD Million) Table 11. Global Oral Contrast Agent Key Company Manufacturing Base & Headquarters Table 12. Global Oral Contrast Agent Company, Product Type & Application Table 13. Global Oral Contrast Agent Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global Oral Contrast Agent by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of Microbubble Contrast Media Table 18. Significant Companies of Gadolinium-based Contrast Media Table 19. Significant Companies of Iodinated Contrast Media Table 20. Significant Companies of Barium-based Contrast Media Table 21. Global Oral Contrast Agent Sales Volume by Type 2021 VS 2025 VS 2032 (K Units) Table 22. Global Oral Contrast Agent Sales Volume by Type (2021-2026) & (K Units) Table 23. Global Oral Contrast Agent Sales Volume by Type (2027-2032) & (K Units) Table 24. Global Oral Contrast Agent Sales Volume Share by Type (2021-2026) Table 25. Global Oral Contrast Agent Sales Volume Share by Type (2027-2032) Table 26. Global Oral Contrast Agent Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 27. Global Oral Contrast Agent Sales Value by Type (2021-2026) & (US$ Million) Table 28. Global Oral Contrast Agent Sales Value by Type (2027-2032) & (US$ Million) Table 29. Global Oral Contrast Agent Sales Value Share by Type (2021-2026) Table 30. Global Oral Contrast Agent Sales Value Share by Type (2027-2032) Table 31. Significant Companies of Cardiovascular Disorders Table 32. Significant Companies of Gastrointestinal Disorders Table 33. Significant Companies of Nephrological Disorders Table 34. Significant Companies of Neurological Disorders Table 35. Significant Companies of Musculoskeletal Disorders Table 36. Significant Companies of Cancer Table 37. Global Oral Contrast Agent Sales Volume by Application 2021 VS 2025 VS 2032 (K Units) Table 38. Global Oral Contrast Agent Sales Volume by Application (2021-2026) & (K Units) Table 39. Global Oral Contrast Agent Sales Volume by Application (2027-2032) & (K Units) Table 40. Global Oral Contrast Agent Sales Volume Share by Application (2021-2026) Table 41. Global Oral Contrast Agent Sales Volume Share by Application (2027-2032) Table 42. Global Oral Contrast Agent Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 43. Global Oral Contrast Agent Sales Value by Application (2021-2026) & (US$ Million) Table 44. Global Oral Contrast Agent Sales Value by Application (2027-2032) & (US$ Million) Table 45. Global Oral Contrast Agent Sales Value Share by Application (2021-2026) Table 46. Global Oral Contrast Agent Sales Value Share by Application (2027-2032) Table 47. Global Oral Contrast Agent Sales by Region: 2021 VS 2025 VS 2032 (K Units) Table 48. Global Oral Contrast Agent Sales by Region (2021-2026) & (K Units) Table 49. Global Oral Contrast Agent Sales Market Share by Region (2021-2026) Table 50. Global Oral Contrast Agent Sales by Region (2027-2032) & (K Units) Table 51. Global Oral Contrast Agent Sales Market Share by Region (2027-2032) Table 52. Global Oral Contrast Agent Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 53. Global Oral Contrast Agent Sales Value by Region (2021-2026) & (US$ Million) Table 54. Global Oral Contrast Agent Sales Value Share by Region (2021-2026) Table 55. Global Oral Contrast Agent Sales Value by Region (2027-2032) & (US$ Million) Table 56. Global Oral Contrast Agent Sales Value Share by Region (2027-2032) Table 57. Global Oral Contrast Agent Market Average Price (US$/Unit) by Region (2021-2026) Table 58. Global Oral Contrast Agent Market Average Price (US$/Unit) by Region (2027-2032) Table 59. Global Oral Contrast Agent Sales by Country: 2021 VS 2025 VS 2032 (K Units) Table 60. Global Oral Contrast Agent Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 61. Global Oral Contrast Agent Sales by Country (2021-2026) & (K Units) Table 62. Global Oral Contrast Agent Sales Market Share by Country (2021-2026) Table 63. Global Oral Contrast Agent Sales by Country (2027-2032) & (K Units) Table 64. Global Oral Contrast Agent Sales Market Share by Country (2027-2032) Table 65. Global Oral Contrast Agent Sales Value by Country (2021-2026) & (US$ Million) Table 66. Global Oral Contrast Agent Sales Value Market Share by Country (2021-2026) Table 67. Global Oral Contrast Agent Sales Value by Country (2027-2032) & (US$ Million) Table 68. Global Oral Contrast Agent Sales Value Market Share by Country (2027-2032) Table 69. Daiichi Sankyo (Japan) Company Information Table 70. Daiichi Sankyo (Japan) Business Overview Table 71. Daiichi Sankyo (Japan) Oral Contrast Agent Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 72. Daiichi Sankyo (Japan) Oral Contrast Agent Product Portfolio Table 73. Daiichi Sankyo (Japan) Recent Development Table 74. Bayer HealthCare (Germany) Company Information Table 75. Bayer HealthCare (Germany) Business Overview Table 76. Bayer HealthCare (Germany) Oral Contrast Agent Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 77. Bayer HealthCare (Germany) Oral Contrast Agent Product Portfolio Table 78. Bayer HealthCare (Germany) Recent Development Table 79. Unijules Life Sciences (India) Company Information Table 80. Unijules Life Sciences (India) Business Overview Table 81. Unijules Life Sciences (India) Oral Contrast Agent Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 82. Unijules Life Sciences (India) Oral Contrast Agent Product Portfolio Table 83. Unijules Life Sciences (India) Recent Development Table 84. Taejoon Pharm (South Korea) Company Information Table 85. Taejoon Pharm (South Korea) Business Overview Table 86. Taejoon Pharm (South Korea) Oral Contrast Agent Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 87. Taejoon Pharm (South Korea) Oral Contrast Agent Product Portfolio Table 88. Taejoon Pharm (South Korea) Recent Development Table 89. Spago Nanomedicine (Sweden) Company Information Table 90. Spago Nanomedicine (Sweden) Business Overview Table 91. Spago Nanomedicine (Sweden) Oral Contrast Agent Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 92. Spago Nanomedicine (Sweden) Oral Contrast Agent Product Portfolio Table 93. Spago Nanomedicine (Sweden) Recent Development Table 94. Magnus Health (India) Company Information Table 95. Magnus Health (India) Business Overview Table 96. Magnus Health (India) Oral Contrast Agent Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 97. Magnus Health (India) Oral Contrast Agent Product Portfolio Table 98. Magnus Health (India) Recent Development Table 99. Lantheus (US) Company Information Table 100. Lantheus (US) Business Overview Table 101. Lantheus (US) Oral Contrast Agent Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 102. Lantheus (US) Oral Contrast Agent Product Portfolio Table 103. Lantheus (US) Recent Development Table 104. Jodas (India) Company Information Table 105. Jodas (India) Business Overview Table 106. Jodas (India) Oral Contrast Agent Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 107. Jodas (India) Oral Contrast Agent Product Portfolio Table 108. Jodas (India) Recent Development Table 109. J.B. Chemicals and Pharmaceuticals (India) Company Information Table 110. J.B. Chemicals and Pharmaceuticals (India) Business Overview Table 111. J.B. Chemicals and Pharmaceuticals (India) Oral Contrast Agent Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 112. J.B. Chemicals and Pharmaceuticals (India) Oral Contrast Agent Product Portfolio Table 113. J.B. Chemicals and Pharmaceuticals (India) Recent Development Table 114. Guerbet (France) Company Information Table 115. Guerbet (France) Business Overview Table 116. Guerbet (France) Oral Contrast Agent Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 117. Guerbet (France) Oral Contrast Agent Product Portfolio Table 118. Guerbet (France) Recent Development Table 119. GE Healthcare (US) Company Information Table 120. GE Healthcare (US) Business Overview Table 121. GE Healthcare (US) Oral Contrast Agent Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 122. GE Healthcare (US) Oral Contrast Agent Product Portfolio Table 123. GE Healthcare (US) Recent Development Table 124. Bracco Imaging (Italy) Company Information Table 125. Bracco Imaging (Italy) Business Overview Table 126. Bracco Imaging (Italy) Oral Contrast Agent Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 127. Bracco Imaging (Italy) Oral Contrast Agent Product Portfolio Table 128. Bracco Imaging (Italy) Recent Development Table 129. Key Raw Materials Table 130. Raw Materials Key Suppliers Table 131. Oral Contrast Agent Distributors List Table 132. Oral Contrast Agent Customers List Table 133. Research Programs/Design for This Report Table 134. Authors List of This Report Table 135. Secondary Sources Table 136. Primary Sources List of Figures Figure 1. Oral Contrast Agent Product Image Figure 2. Global Oral Contrast Agent Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Oral Contrast Agent Sales Value (2021-2032) & (US$ Million) Figure 4. Global Oral Contrast Agent Sales (2021-2032) & (K Units) Figure 5. Global Oral Contrast Agent Sales Average Price (US$/Unit) & (2021-2032) Figure 6. Global Oral Contrast Agent Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. Microbubble Contrast Media Image Figure 10. Gadolinium-based Contrast Media Image Figure 11. Iodinated Contrast Media Image Figure 12. Barium-based Contrast Media Image Figure 13. Global Oral Contrast Agent Sales Volume by Type (2021 VS 2025 VS 2032) & (K Units) Figure 14. Global Oral Contrast Agent Sales Volume Share 2021 VS 2025 VS 2032 Figure 15. Global Oral Contrast Agent Sales Volume Share by Type (2021-2032) Figure 16. Global Oral Contrast Agent Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 17. Global Oral Contrast Agent Sales Value Share 2021 VS 2025 VS 2032 Figure 18. Global Oral Contrast Agent Sales Value Share by Type (2021-2032) Figure 19. Cardiovascular Disorders Image Figure 20. Gastrointestinal Disorders Image Figure 21. Nephrological Disorders Image Figure 22. Neurological Disorders Image Figure 23. Musculoskeletal Disorders Image Figure 24. Cancer Image Figure 25. Global Oral Contrast Agent Sales Volume by Application (2021 VS 2025 VS 2032) & (K Units) Figure 26. Global Oral Contrast Agent Sales Volume Share 2021 VS 2025 VS 2032 Figure 27. Global Oral Contrast Agent Sales Volume Share by Application (2021-2032) Figure 28. Global Oral Contrast Agent Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 29. Global Oral Contrast Agent Sales Value Share 2021 VS 2025 VS 2032 Figure 30. Global Oral Contrast Agent Sales Value Share by Application (2021-2032) Figure 31. Global Oral Contrast Agent Sales by Region: 2021 VS 2025 VS 2032 (K Units) Figure 32. Global Oral Contrast Agent Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 33. Global Oral Contrast Agent Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 34. Global Oral Contrast Agent Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 35. North America Oral Contrast Agent Sales Value (2021-2032) & (US$ Million) Figure 36. North America Oral Contrast Agent Sales Value Share by Country (%), 2025 VS 2032 Figure 37. Europe Oral Contrast Agent Sales Value (2021-2032) & (US$ Million) Figure 38. Europe Oral Contrast Agent Sales Value Share by Country (%), 2025 VS 2032 Figure 39. Asia-Pacific Oral Contrast Agent Sales Value (2021-2032) & (US$ Million) Figure 40. Asia-Pacific Oral Contrast Agent Sales Value Share by Country (%), 2025 VS 2032 Figure 41. South America Oral Contrast Agent Sales Value (2021-2032) & (US$ Million) Figure 42. South America Oral Contrast Agent Sales Value Share by Country (%), 2025 VS 2032 Figure 43. Middle East & Africa Oral Contrast Agent Sales Value (2021-2032) & (US$ Million) Figure 44. Middle East & Africa Oral Contrast Agent Sales Value Share by Country (%), 2025 VS 2032 Figure 45. USA Oral Contrast Agent Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 46. USA Oral Contrast Agent Sales Value Share by Type, 2025 VS 2032 & (%) Figure 47. USA Oral Contrast Agent Sales Value Share by Application, 2025 VS 2032 & (%) Figure 48. Canada Oral Contrast Agent Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 49. Canada Oral Contrast Agent Sales Value Share by Type, 2025 VS 2032 & (%) Figure 50. Canada Oral Contrast Agent Sales Value Share by Application, 2025 VS 2032 & (%) Figure 51. Mexico Oral Contrast Agent Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 52. Mexico Oral Contrast Agent Sales Value Share by Type, 2025 VS 2032 & (%) Figure 53. Mexico Oral Contrast Agent Sales Value Share by Application, 2025 VS 2032 & (%) Figure 54. Germany Oral Contrast Agent Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 55. Germany Oral Contrast Agent Sales Value Share by Type, 2025 VS 2032 & (%) Figure 56. Germany Oral Contrast Agent Sales Value Share by Application, 2025 VS 2032 & (%) Figure 57. France Oral Contrast Agent Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 58. France Oral Contrast Agent Sales Value Share by Type, 2025 VS 2032 & (%) Figure 59. France Oral Contrast Agent Sales Value Share by Application, 2025 VS 2032 & (%) Figure 60. U.K. Oral Contrast Agent Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 61. U.K. Oral Contrast Agent Sales Value Share by Type, 2025 VS 2032 & (%) Figure 62. U.K. Oral Contrast Agent Sales Value Share by Application, 2025 VS 2032 & (%) Figure 63. Italy Oral Contrast Agent Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 64. Italy Oral Contrast Agent Sales Value Share by Type, 2025 VS 2032 & (%) Figure 65. Italy Oral Contrast Agent Sales Value Share by Application, 2025 VS 2032 & (%) Figure 66. Spain Oral Contrast Agent Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 67. Spain Oral Contrast Agent Sales Value Share by Type, 2025 VS 2032 & (%) Figure 68. Spain Oral Contrast Agent Sales Value Share by Application, 2025 VS 2032 & (%) Figure 69. Russia Oral Contrast Agent Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 70. Russia Oral Contrast Agent Sales Value Share by Type, 2025 VS 2032 & (%) Figure 71. Russia Oral Contrast Agent Sales Value Share by Application, 2025 VS 2032 & (%) Figure 72. Netherlands Oral Contrast Agent Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 73. Netherlands Oral Contrast Agent Sales Value Share by Type, 2025 VS 2032 & (%) Figure 74. Netherlands Oral Contrast Agent Sales Value Share by Application, 2025 VS 2032 & (%) Figure 75. Nordic Countries Oral Contrast Agent Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 76. Nordic Countries Oral Contrast Agent Sales Value Share by Type, 2025 VS 2032 & (%) Figure 77. Nordic Countries Oral Contrast Agent Sales Value Share by Application, 2025 VS 2032 & (%) Figure 78. China Oral Contrast Agent Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 79. China Oral Contrast Agent Sales Value Share by Type, 2025 VS 2032 & (%) Figure 80. China Oral Contrast Agent Sales Value Share by Application, 2025 VS 2032 & (%) Figure 81. Japan Oral Contrast Agent Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 82. Japan Oral Contrast Agent Sales Value Share by Type, 2025 VS 2032 & (%) Figure 83. Japan Oral Contrast Agent Sales Value Share by Application, 2025 VS 2032 & (%) Figure 84. South Korea Oral Contrast Agent Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 85. South Korea Oral Contrast Agent Sales Value Share by Type, 2025 VS 2032 & (%) Figure 86. South Korea Oral Contrast Agent Sales Value Share by Application, 2025 VS 2032 & (%) Figure 87. India Oral Contrast Agent Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 88. India Oral Contrast Agent Sales Value Share by Type, 2025 VS 2032 & (%) Figure 89. India Oral Contrast Agent Sales Value Share by Application, 2025 VS 2032 & (%) Figure 90. Australia Oral Contrast Agent Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 91. Australia Oral Contrast Agent Sales Value Share by Type, 2025 VS 2032 & (%) Figure 92. Australia Oral Contrast Agent Sales Value Share by Application, 2025 VS 2032 & (%) Figure 93. Southeast Asia Oral Contrast Agent Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 94. Southeast Asia Oral Contrast Agent Sales Value Share by Type, 2025 VS 2032 & (%) Figure 95. Southeast Asia Oral Contrast Agent Sales Value Share by Application, 2025 VS 2032 & (%) Figure 96. Brazil Oral Contrast Agent Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 97. Brazil Oral Contrast Agent Sales Value Share by Type, 2025 VS 2032 & (%) Figure 98. Brazil Oral Contrast Agent Sales Value Share by Application, 2025 VS 2032 & (%) Figure 99. Argentina Oral Contrast Agent Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 100. Argentina Oral Contrast Agent Sales Value Share by Type, 2025 VS 2032 & (%) Figure 101. Argentina Oral Contrast Agent Sales Value Share by Application, 2025 VS 2032 & (%) Figure 102. Chile Oral Contrast Agent Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 103. Chile Oral Contrast Agent Sales Value Share by Type, 2025 VS 2032 & (%) Figure 104. Chile Oral Contrast Agent Sales Value Share by Application, 2025 VS 2032 & (%) Figure 105. Colombia Oral Contrast Agent Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 106. Colombia Oral Contrast Agent Sales Value Share by Type, 2025 VS 2032 & (%) Figure 107. Colombia Oral Contrast Agent Sales Value Share by Application, 2025 VS 2032 & (%) Figure 108. Peru Oral Contrast Agent Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 109. Peru Oral Contrast Agent Sales Value Share by Type, 2025 VS 2032 & (%) Figure 110. Peru Oral Contrast Agent Sales Value Share by Application, 2025 VS 2032 & (%) Figure 111. Saudi Arabia Oral Contrast Agent Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 112. Saudi Arabia Oral Contrast Agent Sales Value Share by Type, 2025 VS 2032 & (%) Figure 113. Saudi Arabia Oral Contrast Agent Sales Value Share by Application, 2025 VS 2032 & (%) Figure 114. Israel Oral Contrast Agent Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 115. Israel Arabia Oral Contrast Agent Sales Value Share by Type, 2025 VS 2032 & (%) Figure 116. Israel Arabia Oral Contrast Agent Sales Value Share by Application, 2025 VS 2032 & (%) Figure 117. UAE Oral Contrast Agent Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 118. UAE Oral Contrast Agent Sales Value Share by Type, 2025 VS 2032 & (%) Figure 119. UAE Oral Contrast Agent Sales Value Share by Application, 2025 VS 2032 & (%) Figure 120. Turkey Oral Contrast Agent Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 121. Turkey Oral Contrast Agent Sales Value Share by Type, 2025 VS 2032 & (%) Figure 122. Turkey Oral Contrast Agent Sales Value Share by Application, 2025 VS 2032 & (%) Figure 123. Iran Oral Contrast Agent Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 124. Iran Oral Contrast Agent Sales Value Share by Type, 2025 VS 2032 & (%) Figure 125. Iran Oral Contrast Agent Sales Value Share by Application, 2025 VS 2032 & (%) Figure 126. Egypt Oral Contrast Agent Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 127. Egypt Oral Contrast Agent Sales Value Share by Type, 2025 VS 2032 & (%) Figure 128. Egypt Oral Contrast Agent Sales Value Share by Application, 2025 VS 2032 & (%) Figure 129. Oral Contrast Agent Value Chain Figure 130. Manufacturing Cost Structure Figure 131. Oral Contrast Agent Sales Mode & Process Figure 132. Direct Comparison with Distribution Share Figure 133. Distributors Profiles Figure 134. Years Considered Figure 135. Research Process Figure 136. Key Executives Interviewed

Scope & coverage.

Types
  • Microbubble Contrast Media
  • Gadolinium-based Contrast Media
  • Iodinated Contrast Media
  • Barium-based Contrast Media
Applications
  • Cardiovascular Disorders
  • Gastrointestinal Disorders
  • Nephrological Disorders
  • Neurological Disorders
  • Musculoskeletal Disorders
  • Cancer
Companies covered
  • Daiichi Sankyo (Japan)
  • Bayer HealthCare (Germany)
  • Unijules Life Sciences (India)
  • Taejoon Pharm (South Korea)
  • Spago Nanomedicine (Sweden)
  • Magnus Health (India)
  • Lantheus (US)
  • Jodas (India)
  • J.B. Chemicals and Pharmaceuticals (India)
  • Guerbet (France)
  • GE Healthcare (US)
  • Bracco Imaging (Italy)

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Oral Contrast Agent Sales Value (2021-2032)
  4. 1.2.2 Global Oral Contrast Agent Sales Volume (2021-2032)
  5. 1.2.3 Global Oral Contrast Agent Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 Oral Contrast Agent Market Dynamics
  1. 2.1 Oral Contrast Agent Industry Trends
  2. 2.2 Oral Contrast Agent Industry Drivers
  3. 2.3 Oral Contrast Agent Industry Opportunities and Challenges
  4. 2.4 Oral Contrast Agent Industry Restraints
3 Oral Contrast Agent Market by Company
  1. 3.1 Global Oral Contrast Agent Company Revenue Ranking in 2025
  2. 3.2 Global Oral Contrast Agent Revenue by Company (2021-2026)
  3. 3.3 Global Oral Contrast Agent Sales Volume by Company (2021-2026)
  4. 3.4 Global Oral Contrast Agent Average Price by Company (2021-2026)
  5. 3.5 Global Oral Contrast Agent Company Ranking (2024-2026)
  6. 3.6 Global Oral Contrast Agent Company Manufacturing Base and Headquarters
  7. 3.7 Global Oral Contrast Agent Company Product Type and Application
  8. 3.8 Global Oral Contrast Agent Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global Oral Contrast Agent Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 Oral Contrast Agent Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 Oral Contrast Agent Market by Type
  1. 4.1 Oral Contrast Agent Type Introduction
  2. 4.1.1 Microbubble Contrast Media
  3. 4.1.2 Gadolinium-based Contrast Media
  4. 4.1.3 Iodinated Contrast Media
  5. 4.1.4 Barium-based Contrast Media
  6. 4.2 Global Oral Contrast Agent Sales Volume by Type
  7. 4.2.1 Global Oral Contrast Agent Sales Volume by Type (2021 VS 2025 VS 2032)
  8. 4.2.2 Global Oral Contrast Agent Sales Volume by Type (2021-2032)
  9. 4.2.3 Global Oral Contrast Agent Sales Volume Share by Type (2021-2032)
  10. 4.3 Global Oral Contrast Agent Sales Value by Type
  11. 4.3.1 Global Oral Contrast Agent Sales Value by Type (2021 VS 2025 VS 2032)
  12. 4.3.2 Global Oral Contrast Agent Sales Value by Type (2021-2032)
  13. 4.3.3 Global Oral Contrast Agent Sales Value Share by Type (2021-2032)
5 Oral Contrast Agent Market by Application
  1. 5.1 Oral Contrast Agent Application Introduction
  2. 5.1.1 Cardiovascular Disorders
  3. 5.1.2 Gastrointestinal Disorders
  4. 5.1.3 Nephrological Disorders
  5. 5.1.4 Neurological Disorders
  6. 5.1.5 Musculoskeletal Disorders
  7. 5.1.6 Cancer
  8. 5.2 Global Oral Contrast Agent Sales Volume by Application
  9. 5.2.1 Global Oral Contrast Agent Sales Volume by Application (2021 VS 2025 VS 2032)
  10. 5.2.2 Global Oral Contrast Agent Sales Volume by Application (2021-2032)
  11. 5.2.3 Global Oral Contrast Agent Sales Volume Share by Application (2021-2032)
  12. 5.3 Global Oral Contrast Agent Sales Value by Application
  13. 5.3.1 Global Oral Contrast Agent Sales Value by Application (2021 VS 2025 VS 2032)
  14. 5.3.2 Global Oral Contrast Agent Sales Value by Application (2021-2032)
  15. 5.3.3 Global Oral Contrast Agent Sales Value Share by Application (2021-2032)
6 Oral Contrast Agent Regional Sales and Value Analysis
  1. 6.1 Global Oral Contrast Agent Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Oral Contrast Agent Sales by Region (2021-2032)
  3. 6.2.1 Global Oral Contrast Agent Sales by Region: 2021-2026
  4. 6.2.2 Global Oral Contrast Agent Sales by Region (2027-2032)
  5. 6.3 Global Oral Contrast Agent Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global Oral Contrast Agent Sales Value by Region (2021-2032)
  7. 6.4.1 Global Oral Contrast Agent Sales Value by Region: 2021-2026
  8. 6.4.2 Global Oral Contrast Agent Sales Value by Region (2027-2032)
  9. 6.5 Global Oral Contrast Agent Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America Oral Contrast Agent Sales Value (2021-2032)
  12. 6.6.2 North America Oral Contrast Agent Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe Oral Contrast Agent Sales Value (2021-2032)
  15. 6.7.2 Europe Oral Contrast Agent Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific Oral Contrast Agent Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific Oral Contrast Agent Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America Oral Contrast Agent Sales Value (2021-2032)
  21. 6.9.2 South America Oral Contrast Agent Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa Oral Contrast Agent Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa Oral Contrast Agent Sales Value Share by Country, 2025 VS 2032
7 Oral Contrast Agent Country-level Sales and Value Analysis
  1. 7.1 Global Oral Contrast Agent Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Oral Contrast Agent Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global Oral Contrast Agent Sales by Country (2021-2032)
  4. 7.3.1 Global Oral Contrast Agent Sales by Country (2021-2026)
  5. 7.3.2 Global Oral Contrast Agent Sales by Country (2027-2032)
  6. 7.4 Global Oral Contrast Agent Sales Value by Country (2021-2032)
  7. 7.4.1 Global Oral Contrast Agent Sales Value by Country (2021-2026)
  8. 7.4.2 Global Oral Contrast Agent Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA Oral Contrast Agent Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA Oral Contrast Agent Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA Oral Contrast Agent Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada Oral Contrast Agent Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada Oral Contrast Agent Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada Oral Contrast Agent Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico Oral Contrast Agent Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico Oral Contrast Agent Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico Oral Contrast Agent Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany Oral Contrast Agent Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany Oral Contrast Agent Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany Oral Contrast Agent Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France Oral Contrast Agent Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France Oral Contrast Agent Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France Oral Contrast Agent Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. Oral Contrast Agent Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. Oral Contrast Agent Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. Oral Contrast Agent Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy Oral Contrast Agent Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy Oral Contrast Agent Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy Oral Contrast Agent Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain Oral Contrast Agent Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain Oral Contrast Agent Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain Oral Contrast Agent Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia Oral Contrast Agent Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia Oral Contrast Agent Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia Oral Contrast Agent Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands Oral Contrast Agent Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands Oral Contrast Agent Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands Oral Contrast Agent Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries Oral Contrast Agent Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries Oral Contrast Agent Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries Oral Contrast Agent Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China Oral Contrast Agent Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China Oral Contrast Agent Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China Oral Contrast Agent Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan Oral Contrast Agent Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan Oral Contrast Agent Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan Oral Contrast Agent Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea Oral Contrast Agent Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea Oral Contrast Agent Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea Oral Contrast Agent Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India Oral Contrast Agent Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India Oral Contrast Agent Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India Oral Contrast Agent Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia Oral Contrast Agent Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia Oral Contrast Agent Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia Oral Contrast Agent Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia Oral Contrast Agent Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia Oral Contrast Agent Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia Oral Contrast Agent Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil Oral Contrast Agent Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil Oral Contrast Agent Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil Oral Contrast Agent Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina Oral Contrast Agent Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina Oral Contrast Agent Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina Oral Contrast Agent Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile Oral Contrast Agent Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile Oral Contrast Agent Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile Oral Contrast Agent Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia Oral Contrast Agent Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia Oral Contrast Agent Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia Oral Contrast Agent Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru Oral Contrast Agent Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru Oral Contrast Agent Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru Oral Contrast Agent Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia Oral Contrast Agent Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia Oral Contrast Agent Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia Oral Contrast Agent Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel Oral Contrast Agent Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel Oral Contrast Agent Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel Oral Contrast Agent Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE Oral Contrast Agent Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE Oral Contrast Agent Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE Oral Contrast Agent Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey Oral Contrast Agent Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey Oral Contrast Agent Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey Oral Contrast Agent Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran Oral Contrast Agent Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran Oral Contrast Agent Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran Oral Contrast Agent Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt Oral Contrast Agent Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt Oral Contrast Agent Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt Oral Contrast Agent Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Daiichi Sankyo (Japan)
  2. 8.1.1 Daiichi Sankyo (Japan) Company Information
  3. 8.1.2 Daiichi Sankyo (Japan) Business Overview
  4. 8.1.3 Daiichi Sankyo (Japan) Oral Contrast Agent Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 Daiichi Sankyo (Japan) Oral Contrast Agent Product Portfolio
  6. 8.1.5 Daiichi Sankyo (Japan) Recent Developments
  7. 8.2 Bayer HealthCare (Germany)
  8. 8.2.1 Bayer HealthCare (Germany) Company Information
  9. 8.2.2 Bayer HealthCare (Germany) Business Overview
  10. 8.2.3 Bayer HealthCare (Germany) Oral Contrast Agent Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 Bayer HealthCare (Germany) Oral Contrast Agent Product Portfolio
  12. 8.2.5 Bayer HealthCare (Germany) Recent Developments
  13. 8.3 Unijules Life Sciences (India)
  14. 8.3.1 Unijules Life Sciences (India) Company Information
  15. 8.3.2 Unijules Life Sciences (India) Business Overview
  16. 8.3.3 Unijules Life Sciences (India) Oral Contrast Agent Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 Unijules Life Sciences (India) Oral Contrast Agent Product Portfolio
  18. 8.3.5 Unijules Life Sciences (India) Recent Developments
  19. 8.4 Taejoon Pharm (South Korea)
  20. 8.4.1 Taejoon Pharm (South Korea) Company Information
  21. 8.4.2 Taejoon Pharm (South Korea) Business Overview
  22. 8.4.3 Taejoon Pharm (South Korea) Oral Contrast Agent Sales, Value and Gross Margin (2021-2026)
  23. 8.4.4 Taejoon Pharm (South Korea) Oral Contrast Agent Product Portfolio
  24. 8.4.5 Taejoon Pharm (South Korea) Recent Developments
  25. 8.5 Spago Nanomedicine (Sweden)
  26. 8.5.1 Spago Nanomedicine (Sweden) Company Information
  27. 8.5.2 Spago Nanomedicine (Sweden) Business Overview
  28. 8.5.3 Spago Nanomedicine (Sweden) Oral Contrast Agent Sales, Value and Gross Margin (2021-2026)
  29. 8.5.4 Spago Nanomedicine (Sweden) Oral Contrast Agent Product Portfolio
  30. 8.5.5 Spago Nanomedicine (Sweden) Recent Developments
  31. 8.6 Magnus Health (India)
  32. 8.6.1 Magnus Health (India) Company Information
  33. 8.6.2 Magnus Health (India) Business Overview
  34. 8.6.3 Magnus Health (India) Oral Contrast Agent Sales, Value and Gross Margin (2021-2026)
  35. 8.6.4 Magnus Health (India) Oral Contrast Agent Product Portfolio
  36. 8.6.5 Magnus Health (India) Recent Developments
  37. 8.7 Lantheus (US)
  38. 8.7.1 Lantheus (US) Company Information
  39. 8.7.2 Lantheus (US) Business Overview
  40. 8.7.3 Lantheus (US) Oral Contrast Agent Sales, Value and Gross Margin (2021-2026)
  41. 8.7.4 Lantheus (US) Oral Contrast Agent Product Portfolio
  42. 8.7.5 Lantheus (US) Recent Developments
  43. 8.8 Jodas (India)
  44. 8.8.1 Jodas (India) Company Information
  45. 8.8.2 Jodas (India) Business Overview
  46. 8.8.3 Jodas (India) Oral Contrast Agent Sales, Value and Gross Margin (2021-2026)
  47. 8.8.4 Jodas (India) Oral Contrast Agent Product Portfolio
  48. 8.8.5 Jodas (India) Recent Developments
  49. 8.9 J.B. Chemicals and Pharmaceuticals (India)
  50. 8.9.1 J.B. Chemicals and Pharmaceuticals (India) Company Information
  51. 8.9.2 J.B. Chemicals and Pharmaceuticals (India) Business Overview
  52. 8.9.3 J.B. Chemicals and Pharmaceuticals (India) Oral Contrast Agent Sales, Value and Gross Margin (2021-2026)
  53. 8.9.4 J.B. Chemicals and Pharmaceuticals (India) Oral Contrast Agent Product Portfolio
  54. 8.9.5 J.B. Chemicals and Pharmaceuticals (India) Recent Developments
  55. 8.10 Guerbet (France)
  56. 8.10.1 Guerbet (France) Company Information
  57. 8.10.2 Guerbet (France) Business Overview
  58. 8.10.3 Guerbet (France) Oral Contrast Agent Sales, Value and Gross Margin (2021-2026)
  59. 8.10.4 Guerbet (France) Oral Contrast Agent Product Portfolio
  60. 8.10.5 Guerbet (France) Recent Developments
  61. 8.11 GE Healthcare (US)
  62. 8.11.1 GE Healthcare (US) Company Information
  63. 8.11.2 GE Healthcare (US) Business Overview
  64. 8.11.3 GE Healthcare (US) Oral Contrast Agent Sales, Value and Gross Margin (2021-2026)
  65. 8.11.4 GE Healthcare (US) Oral Contrast Agent Product Portfolio
  66. 8.11.5 GE Healthcare (US) Recent Developments
  67. 8.12 Bracco Imaging (Italy)
  68. 8.12.1 Bracco Imaging (Italy) Company Information
  69. 8.12.2 Bracco Imaging (Italy) Business Overview
  70. 8.12.3 Bracco Imaging (Italy) Oral Contrast Agent Sales, Value and Gross Margin (2021-2026)
  71. 8.12.4 Bracco Imaging (Italy) Oral Contrast Agent Product Portfolio
  72. 8.12.5 Bracco Imaging (Italy) Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Oral Contrast Agent Value Chain Analysis
  2. 9.1.1 Oral Contrast Agent Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Oral Contrast Agent Sales Mode & Process
  6. 9.2 Oral Contrast Agent Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Oral Contrast Agent Distributors
  9. 9.2.3 Oral Contrast Agent Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst